Edition:
United States

Admedus Ltd (AHZ.AX)

AHZ.AX on Australia Stock Exchange

0.32AUD
28 Apr 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
$0.32
Open
$0.32
Day's High
$0.33
Day's Low
$0.32
Volume
125,283
Avg. Vol
328,361
52-wk High
$0.55
52-wk Low
$0.28

AHZ.AX

Chart for AHZ.AX

About

Admedus Limited is a healthcare company, which develops, commercializes and distributes medical technologies and devices. The Company is engaged in the sale and distribution of the infusion medical device and the ADAPT tissue portfolio with a particular focus in the area of cardiovascular Neonatal repair. The Company operates... (more)

Overall

Beta: 1.09
Market Cap(Mil.): $82.81
Shares Outstanding(Mil.): 254.80
Dividend: --
Yield (%): --

Financials

  AHZ.AX Industry Sector
P/E (TTM): -- 34.67 30.12
EPS (TTM): -0.08 -- --
ROI: -59.17 12.55 13.28
ROE: -59.13 14.56 14.44

BRIEF-Admedus Ltd appoints John Seaberg as Chairman

* John seaberg will be succeeding wayne paterson Source text for Eikon: Further company coverage:

Mar 13 2017

BRIEF-Admedus has received market approval for Cardiocel in United Arab Emirates

* Has received market approval for Cardiocel in United Arab Emirates Source text for Eikon: Further company coverage:

Nov 20 2016

More From Around the Web

Earnings vs. Estimates